Type I versus type II cytokine levels as a function of SOD1 G93A mouse amyotrophic lateral sclerosis disease progression
Amyotrophic Lateral Sclerosis (ALS) is a fatal motoneuron disease that is characterized by the degradation of neurons throughout the central nervous system. Inflammation have been cited a key contributor to ALS neurodegeneration, but the timeline of cytokine upregulation remains unresolved. The goal...
Main Authors: | Amilia eJeyachandran, Benjamin eMertens, Eric A McKissick, Cassie S Mitchell |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2015-12-01
|
Series: | Frontiers in Cellular Neuroscience |
Subjects: | |
Online Access: | http://journal.frontiersin.org/Journal/10.3389/fncel.2015.00462/full |
Similar Items
-
Regional Differences in Heat Shock Protein 25 Expression in Brain and Spinal Cord Astrocytes of Wild-Type and SOD1 <sup>G93A</sup> Mice
by: Rebecca San Gil, et al.
Published: (2021-05-01) -
Copper Homeostasis as a Therapeutic Target in Amyotrophic Lateral Sclerosis with SOD1 Mutations
by: Eiichi Tokuda, et al.
Published: (2016-04-01) -
17β-estradiol rescues spinal motoneurons from AMPA-induced toxicity: A role for glial cells
by: Paola Platania, et al.
Published: (2005-11-01) -
Chitotriosidase, a biomarker of amyotrophic lateral sclerosis, accentuates neurodegeneration in spinal motor neurons through neuroinflammation
by: Anu Mary Varghese, et al.
Published: (2020-08-01) -
Identification of Genetic Modifiers of TDP-43: Inflammatory Activation of Astrocytes for Neuroinflammation
by: Jae-Hong Kim, et al.
Published: (2021-03-01)